文献速递脊柱脊髓外科

腰椎指数手术前延长非手术治疗使用中的性别差异

Gender Differences in Use of Prolonged Nonoperative Therapies Before Index Lumbar Surgery.
PubMed 文献 · World Neurosurg · 2018-08-27

基于大型保险数据库2007至2016年4133例因症状性腰椎狭窄或滑脱行后路腰椎固定融合术的患者,评估术前最大非手术治疗的使用与费用性别差异。女性使用非甾体抗炎药、腰椎硬膜外类固醇注射、物理和/或作业治疗及肌肉松弛剂的比例显著更高,女性人均直接费用为2296.02美元,男性为2011.35美元。结果提示融合术前非手术治疗使用存在性别差异。

要点

  • 女性使用非甾体抗炎药、硬膜外类固醇注射、物理和/或作业治疗及肌肉松弛剂的比例显著高于男性。
  • 术前最大非手术治疗总直接费用为9,000,968美元,女性5,549,489美元(人均2296.02美元),男性3,451,479美元(人均2011.35美元)。
  • 女性占队列58.5%,但使用了61.5%的医疗治疗计费单位。

核心结论

  • 结果提示症状性腰椎狭窄或滑脱患者在融合术前非手术治疗的使用存在性别差异。

研究设计与样本

  • 查询大型保险数据库,纳入2007至2016年因症状性腰椎狭窄或滑脱行指数腰椎减压融合术的患者。
  • 仅纳入指数手术前在Humana保险系统内连续活跃≥5年的患者。
  • 使用情况以向患者计费的费用、开具的处方和计费单位数表征。

主要发现

  • 共4133例患者(58.5%为女性)行1、2或3节段后路腰椎器械融合。
  • 女性使用非甾体抗炎药的比例显著更高(P < 0.0001)。
  • 女性使用腰椎硬膜外类固醇注射的比例显著更高(P = 0.0044)。
  • 女性使用物理和/或作业治疗及肌肉松弛剂的比例显著更高(P < 0.0001)。
  • 按使用治疗的患者人均计费药片数归一化后,女性使用更多非甾体抗炎药、阿片类药物和肌肉松弛剂。

关键数值与推荐

  • 术前最大非手术治疗总直接费用为9,000,968美元,男性3,451,479美元(人均2011.35美元),女性5,549,489美元(人均2296.02美元)。
  • 女性占队列58.5%,但使用了61.5%的医疗治疗计费单位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of the present study was to assess for gender-based differences in the usage and cost of maximal nonoperative therapy before spinal fusion surgery in patients with symptomatic lumbar stenosis or spondylolisthesis. METHODS: A large insurance database was queried for patients with symptomatic lumbar stenosis or spondylolisthesis undergoing index lumbar decompression and fusion procedures from 2007 to 2016. This database consists of 20.9 million covered lives and includes private or commercially insured and Medicare Advantage beneficiaries. Only patients continuously active within the Humana insurance system for ≥5 years before the index operation were eligible. Usage was characterized by the cost billed to the patient, prescriptions written, and number of units billed. RESULTS: A total of 4133 patients (58.5% women) underwent 1-, 2-, or 3-level posterior lumbar instrumented fusion. A significantly greater percentage of female patients used nonsteroidal anti-inflammatory drugs (P < 0.0001), lumbar epidural steroid injections (P = 0.0044), physical and/or occupational therapy (P < 0.0001), and muscle relaxants (P < 0.0001). The total direct cost associated with all maximal nonoperative therapy before index spinal fusion was $9,000,968, with men spending $3,451,479 ($2011.35 per patient) and women spending $5,549,489 ($2296.02 per patient). When considering the quantity of units billed, women used 61.5% of the medical therapy units disbursed despite constituting 58.5% of the cohort. When normalized by the number of pills billed per patient using therapy, female patients used more nonsteroidal anti-inflammatory drugs, opioids, and muscle relaxants. CONCLUSIONS: These results suggest that gender differences exist in the use of nonoperative therapies for symptomatic lumbar stenosis or spondylolisthesis before fusion surgery.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Davison MA, Vuong VD, Lilly DT, et al. Gender Differences in Use of Prolonged Nonoperative Therapies Before Index Lumbar Surgery. World Neurosurg. 2018. PMID: 30165230. doi:10.1016/j.wneu.2018.08.131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。